Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4767369
- 86 Pages
- January 2022
- Pharmaceuticals
The United States Rx Irritable Bowel Syndrome (IBS) Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Rx Irritable Bowel Syndrome (IBS) Drugs market, reaching US$ million by the year 2028. As for the Europe Rx Irritable Bowel Syndrome (IBS) Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Rx Irritable Bowel Syndrome (IBS) Drugs players cover Ironwood Pharmaceuticals, Bausch Health, Takeda, and Sebela Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Rx Irritable Bowel Syndrome (IBS) Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
IBS-D Drugs
IBS-C Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Women
Men
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2017-2028
2.1.2 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Type
2.2.1 IBS-D Drugs
2.2.2 IBS-C Drugs
2.2.3 Others
2.3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type
2.3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2022)
2.4 Rx Irritable Bowel Syndrome (IBS) Drugs Segment by Application
2.4.1 Women
2.4.2 Men
2.5 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application
2.5.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2022)
3 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Player
3.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Players
3.1.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2020-2022)
3.1.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Rx Irritable Bowel Syndrome (IBS) Drugs by Regions
4.1 Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions (2017-2022)
4.2 Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth (2017-2022)
4.3 APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth (2017-2022)
4.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022)
5.2 Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
5.3 Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022)
6.2 APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
6.3 APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Rx Irritable Bowel Syndrome (IBS) Drugs by Country (2017-2022)
7.2 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
7.3 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs by Region (2017-2022)
8.2 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Regions (2023-2028)
10.1.1 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Rx Irritable Bowel Syndrome (IBS) Drugs Forecast
10.1.3 APAC Rx Irritable Bowel Syndrome (IBS) Drugs Forecast
10.1.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Forecast
10.1.5 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Forecast
10.2 Americas Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Country (2023-2028)
10.2.1 United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.2.2 Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.2.3 Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.2.4 Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.3 APAC Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Region (2023-2028)
10.3.1 China Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.3.2 Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.3.3 Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.3.4 Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.3.5 India Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.3.6 Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.4 Europe Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Country (2023-2028)
10.4.1 Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.4.2 France Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.4.3 UK Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.4.4 Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.4.5 Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.5 Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.5.2 South Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.5.3 Israel Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.5.4 Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.5.5 GCC Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Forecast
10.6 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Type (2023-2028)
10.7 Global Rx Irritable Bowel Syndrome (IBS) Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Information
11.1.2 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
11.1.3 Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Ironwood Pharmaceuticals Main Business Overview
11.1.5 Ironwood Pharmaceuticals Latest Developments
11.2 Bausch Health
11.2.1 Bausch Health Company Information
11.2.2 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
11.2.3 Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bausch Health Main Business Overview
11.2.5 Bausch Health Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
11.3.3 Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Sebela Pharmaceuticals
11.4.1 Sebela Pharmaceuticals Company Information
11.4.2 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
11.4.3 Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sebela Pharmaceuticals Main Business Overview
11.4.5 Sebela Pharmaceuticals Latest Developments
11.5 Allergan
11.5.1 Allergan Company Information
11.5.2 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
11.5.3 Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Allergan Main Business Overview
11.5.5 Allergan Latest Developments
12 Research Findings and Conclusion
Table 1. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of IBS-D Drugs
Table 3. Major Players of IBS-C Drugs
Table 4. Major Players of Others
Table 5. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2022)
Table 8. Rx Irritable Bowel Syndrome (IBS) Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2022)
Table 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Player (2020-2022)
Table 13. Rx Irritable Bowel Syndrome (IBS) Drugs Key Players Head office and Products Offered
Table 14. Rx Irritable Bowel Syndrome (IBS) Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Regions (2017-2022)
Table 19. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Country (2017-2022)
Table 21. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2022)
Table 23. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2022)
Table 25. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Region (2017-2022)
Table 27. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2022)
Table 29. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2022)
Table 31. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Country (2017-2022)
Table 33. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2022)
Table 35. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Rx Irritable Bowel Syndrome (IBS) Drugs
Table 44. Key Market Challenges & Risks of Rx Irritable Bowel Syndrome (IBS) Drugs
Table 45. Key Industry Trends of Rx Irritable Bowel Syndrome (IBS) Drugs
Table 46. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 52. Ironwood Pharmaceuticals Details, Company Type, Rx Irritable Bowel Syndrome (IBS) Drugs Area Served and Its Competitors
Table 53. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
Table 54. Ironwood Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Ironwood Pharmaceuticals Main Business
Table 56. Ironwood Pharmaceuticals Latest Developments
Table 57. Bausch Health Details, Company Type, Rx Irritable Bowel Syndrome (IBS) Drugs Area Served and Its Competitors
Table 58. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
Table 59. Bausch Health Main Business
Table 60. Bausch Health Rx Irritable Bowel Syndrome (IBS) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bausch Health Latest Developments
Table 62. Takeda Details, Company Type, Rx Irritable Bowel Syndrome (IBS) Drugs Area Served and Its Competitors
Table 63. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
Table 64. Takeda Main Business
Table 65. Takeda Rx Irritable Bowel Syndrome (IBS) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Takeda Latest Developments
Table 67. Sebela Pharmaceuticals Details, Company Type, Rx Irritable Bowel Syndrome (IBS) Drugs Area Served and Its Competitors
Table 68. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
Table 69. Sebela Pharmaceuticals Main Business
Table 70. Sebela Pharmaceuticals Rx Irritable Bowel Syndrome (IBS) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Sebela Pharmaceuticals Latest Developments
Table 72. Allergan Details, Company Type, Rx Irritable Bowel Syndrome (IBS) Drugs Area Served and Its Competitors
Table 73. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Product Offered
Table 74. Allergan Main Business
Table 75. Allergan Rx Irritable Bowel Syndrome (IBS) Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Allergan Latest Developments
List of Figures
Figure 1. Rx Irritable Bowel Syndrome (IBS) Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type in 2021
Figure 7. Rx Irritable Bowel Syndrome (IBS) Drugs in Women
Figure 8. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market: Women (2017-2022) & ($ Millions)
Figure 9. Rx Irritable Bowel Syndrome (IBS) Drugs in Men
Figure 10. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market: Men (2017-2022) & ($ Millions)
Figure 11. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application in 2021
Figure 12. Global Rx Irritable Bowel Syndrome (IBS) Drugs Revenue Market Share by Player in 2021
Figure 13. Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2017-2022 ($ Millions)
Figure 15. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2017-2022 ($ Millions)
Figure 16. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Value Market Share by Country in 2021
Figure 19. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Consumption Market Share by Type in 2021
Figure 20. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application in 2021
Figure 21. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Region in 2021
Figure 26. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application in 2021
Figure 27. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Country in 2021
Figure 34. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type in 2021
Figure 35. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application in 2021
Figure 36. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Market Share by Application in 2021
Figure 44. Egypt Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Rx Irritable Bowel Syndrome (IBS) Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 50. APAC Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 51. Europe Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 53. United States Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Canada Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 57. China Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Japan Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Korea Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 61. India Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Australia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Germany Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 64. France Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 65. UK Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Italy Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Russia Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Spain Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Israel Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Rx Irritable Bowel Syndrome (IBS) Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
